Andover-based TransMedics Group signed a 498K SF lease for 188 Assembly Park Drive at BioMed Realty 's Assembly Innovation ...
Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company" or "Solid"), a life sciences company developing precision genetic medicines for neuromuscular ...
Hong Kong investors can now trade in their first mRNA concept stock, following the strong trading debut for Suzhou Ribo Life ...
Since Dr. Rubinstein began his tenure as Interim CMO in September 2025, the company has achieved significant clinical and ...
The 2025 American Society of Hematology (ASH) meeting in December presented a clear message: scientific innovation and ...
FALCON is a first-in-human, open-label, multi-center Phase 1b clinical trial designed to evaluate the safety and tolerability ...
GRIN Therapeutics begins patient dosing in global phase 3 Beeline trial of investigational radiprodil for GRINRelated neurodevelopmental disorder: New York Monday, January 12, 202 ...
A rapid climate collapse during the Late Ordovician Mass Extinction devastated ocean life and reshuffled Earth’s ecosystems.
Novamigra Therapeutics secures ~€3 million funding to advance first-in-human Phase 1 study of its migraine prophylaxis ...
32 Biosciences revealed its plan to launch a $40 million Series A at this year’s J.P Morgan Healthcare conference, to advance ...
Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.
Disruptions to SBIR/STTR program leave local life sciences and tech innovators facing tougher paths to commercialization.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback